Evaluation of the Effects of Exenatide Administration in Patients with Type 2 Diabetes with Worsened Glycemic Control Caused by Glucocorticoid Therapy

Evaluation of the Effects of Exenatide Administration in Patients with Type 2 Diabetes with Worsened Glycemic Control Caused by Glucocorticoid Therapy

Glucocorticoid-induced hyperglycemia is common in patients with or without known diabetes mellitus. Exenatide, a glucagon-like peptide-1 receptor agonist, improves glycemic control without causing weight gain or hypoglycemia and is currently widely used in patients with type 2 diabetes mellitus. We...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Internal Medicine 2013, Vol.52(1), pp.89-95
Hauptverfasser: Matsuo, Koji, Nambu, Takuo, Matsuda, Yuki, Kanai, Yugo, Yonemitsu, Shin, Muro, Seiji, Oki, Shogo
Format: Artikel
Sprache:eng
Schlagworte:
Adult
Aged
Aged, 80 and over
Blood Glucose - analysis
Blood Glucose - drug effects
diabetes mellitus
Diabetes Mellitus, Type 2 - diagnosis
Diabetes Mellitus, Type 2 - drug therapy
Dose-Response Relationship, Drug
Drug Administration Schedule
Exenatide
Female
Follow-Up Studies
glucocorticoids
Glucocorticoids - adverse effects
Glucocorticoids - therapeutic use
Humans
Hyperglycemia - chemically induced
Hyperglycemia - drug therapy
Hyperglycemia - physiopathology
Hypoglycemic Agents - therapeutic use
incretin
Injections, Subcutaneous
Insulin - therapeutic use
Male
Middle Aged
Peptides - therapeutic use
Risk Assessment
Sampling Studies
Treatment Outcome
Venoms - therapeutic use
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Glucocorticoid-induced hyperglycemia is common in patients with or without known diabetes mellitus. Exenatide, a glucagon-like peptide-1 receptor agonist, improves glycemic control without causing weight gain or hypoglycemia and is currently widely used in patients with type 2 diabetes mellitus. We herein report four cases of patients with type 2 diabetes with worsened glycemic control due to glucocorticoids who were successfully treated with exenatide administration.
ISSN:0918-2918
1349-7235
DOI:10.2169/internalmedicine.52.8622